Semaglutide
Helps manage weight by reducing appetite and improving how your body regulates blood sugar. One of the most clinically studied peptides for weight management.
This peptide is an FDA-approved drug product that can be legally prescribed by licensed clinicians.
The basics
- Generic Name
- semaglutide
- Brand Names
- Ozempic, Wegovy, Rybelsus
- Regulatory Status
- Prescribed by Doctors
- Therapeutic Areas
- Metabolic & Weight Management, Cardiovascular
- Prescribing Specialties
- Primary care, Endocrinology, Obesity medicine, Cardiology
Wellness Goals
What it does
Semaglutide is an FDA-approved medication that your doctor can prescribe. GLP-1 receptor agonist that mimics the incretin hormone GLP-1, enhancing insulin secretion, suppressing glucagon, slowing gastric emptying, and reducing appetite.
How it's taken
Weekly subcutaneous injection (Ozempic, Wegovy)
Daily oral tablet (Rybelsus)
How people access it
Prescribed by any licensed doctor. Filled at a regular retail pharmacy. Covered by many insurance plans, though coverage varies. Telehealth providers can also prescribe it after a virtual consultation.
What doctors prescribe it for
- Type 2 diabetes mellitus (Ozempic, Rybelsus)
- Chronic weight management in adults with obesity or overweight with comorbidities (Wegovy)
- Cardiovascular risk reduction in indicated populations (Wegovy)
Clinicians may prescribe FDA-approved drugs for off-label uses based on their clinical judgment. Off-label indications have not undergone the same FDA review process as the labeled uses listed above.
How to know it's legit
You can independently verify the FDA-approval status of Semaglutide through these free, publicly available databases:
- DailyMed (dailymed.nlm.nih.gov) — Search for Ozempic to find the current FDA-approved labeling, including indications, dosing, warnings, and contraindications.
- Drugs@FDA (accessdata.fda.gov/scripts/cder/daf/) — Search to find the original approval letter, review documents, and approval history.
- FDA Orange Book (orangebook.fda.gov) — Search for therapeutic equivalence evaluations and patent/exclusivity information.
Common Questions
No. Compounded semaglutide is not the same as Ozempic, Wegovy, or Rybelsus. FDA-approved products undergo rigorous manufacturing, testing, and quality controls. Compounded versions are not FDA-approved and may differ in purity, potency, and sterility. The FDA has issued warnings about risks associated with compounded semaglutide products.
Some compounding pharmacies have marketed semaglutide sodium or semaglutide acetate. These salt forms are not the same as the active ingredient in FDA-approved semaglutide products. The FDA has warned that the safety and efficacy of these alternative salt forms have not been established and they should not be considered interchangeable with approved products.
No. Semaglutide is a prescription medication in all its FDA-approved forms. Any source offering semaglutide without a prescription is operating outside legal and safety standards. Always obtain semaglutide through a licensed clinician and a licensed pharmacy.
Want to learn more?
Explore how Semaglutide compares to other options, or dive deeper into how FDA approval works.
Explore All Peptides